Sterile Injectables China

Hey Western Pharma, Scrambling for Real Growth? Revisit the China Opportunity

Mergers and acquisitions, operational rationalization and stock repurchasing will only sustain a company’s bottom line for so long. At some point, healthcare spending levels, even in the United States, will negatively impact price and reimbursement, thus reinstating unit…


China’s Pilot Program Opens Door to Contract Drug Manufacturing

Fresh off launching our company at the CPhI Worldwide Congress in Madrid in October, PaizaBio began business development efforts as the aseptic CMO partner of choice for Western pharmaceutical companies seeking to expand their presence in the burgeoning…